An Analysis of Survival Trends With Allogeneic Blood and Marrow Transplantation
Researchers identified areas of improved outcomes for patients receiving allogeneic blood or marrow transplantation as well as some areas of concern.
Diagnosis & Disease Information
Acute Myeloid Leukemia Survivors at Greater Risk of Long-Term Morbidity After BMT Compared With Healthy Siblings
AML survivors treated with blood or marrow transplantation have a greater risk of grade 3 or higher chronic health conditions, according to a survey that compared the long-term outcomes between survivors and their healthy siblings.
Bone Marrow vs Bloodstream: Stem Cell Source Influences Transplantation Outcomes
Blood stem cells derived from donor bone marrow resulted in better self-reported psychological well-being and fewer GVHD symptoms.
Recently Identified Biomarkers Found to Warn of Chronic Graft-vs-Host Disease in Marrow Transplant Patients
Researchers recently identified CXCL10, a protein that could act as a biomarker for chronic graft-versus-host disease (cGVHD), a long-term adverse effect that develops in some patients after undergoing blood and bone marrow transplant.
Bone Marrow vs PBSCs: Preference of Stem Cell Source for Bone Marrow Failure Varies Worldwide
Sources of stem cells used to treat bone marrow failure vary around the world, with bone marrow harvest more commonly used in areas with more resources. PBSCs are more commonly used in regions with limited resources.
Teamwork Improves Transitioning Blood, Marrow Transplant Patients to Outpatient Unit
Nursing staff satisfaction improved in transition of care for patients from the inpatient to the outpatient blood and marrow transplant (BMT) units.
Managing Aspergillus infection in HSCT recipients
This review discusses common risk factors, treatment, and preventive measures for aspergillosis in hematopoietic stem transplantation recipients.
A subset of antiviral immune cells could prevent CMV infections in bone marrow transplant recipients
A small subset of antiviral immune cells may be enough to fight and even prevent the disease caused by cytomegalovirus (CMV) in patients that receive bone marrow transplants.
New test helps guide treatment for bone marrow transplant patients with GVHD
A new test can assist in the treatment of patients with graft-versus-host disease (GVHD), an often life-threatening complication of bone marrow and stem cell transplants.
Positive study data could improve standard of care for Hodgkin lymphoma
Patients with Hodgkin lymphoma who received brentuximab vedotin after transplantation lived longer without disease progression than patients who received only supportive care, per clinical trial data.
- Loading...
Loading...
Loading... 
Loading...